Unlimited access to the most powerful analytical tools in finance.

Subscribe for $2
Overview
Profile
EBOS Group Stock

EBOS Group Stock EBO.NZ

EBO.NZ
NZEBOE0001S6
724635

Price

34.28
Today +/-
-0.06
Today %
-0.30 %

EBOS Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the EBOS Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the EBOS Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the EBOS Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze EBOS Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

EBOS Group Stock Price History

DateEBOS Group Price
6/23/202534.28 undefined
6/19/202534.39 undefined
6/18/202534.27 undefined
6/17/202534.52 undefined
6/16/202533.84 undefined
6/13/202533.96 undefined
6/12/202534.15 undefined
6/11/202534.27 undefined
6/10/202534.34 undefined
6/9/202534.91 undefined
6/6/202535.07 undefined
6/5/202535.06 undefined
6/4/202534.17 undefined
6/3/202535.32 undefined
5/30/202534.63 undefined
5/29/202534.52 undefined
5/28/202536.15 undefined
5/27/202535.46 undefined
5/26/202535.65 undefined

EBOS Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into EBOS Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by EBOS Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects EBOS Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of EBOS Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into EBOS Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing EBOS Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on EBOS Group’s growth potential.

EBOS Group Revenue, EBIT and net profit per share

DateEBOS Group RevenueEBOS Group EBITEBOS Group Net Income
2027e13.93 B undefined589.82 M undefined346.28 M undefined
2026e13.18 B undefined542.49 M undefined311.17 M undefined
2025e12.3 B undefined485.66 M undefined271.47 M undefined
202413.19 B undefined482.53 M undefined271.55 M undefined
202312.24 B undefined444.86 M undefined253.37 M undefined
202210.73 B undefined345.23 M undefined202.61 M undefined
20219.2 B undefined287.39 M undefined185.3 M undefined
20208.77 B undefined259.7 M undefined162.52 M undefined
20196.93 B undefined225.36 M undefined137.7 M undefined
20186.99 B undefined214.01 M undefined137.27 M undefined
20176.84 B undefined189.77 M undefined119.56 M undefined
20166.43 B undefined179.31 M undefined115 M undefined
20155.85 B undefined163.33 M undefined102.1 M undefined
20145.21 B undefined139.7 M undefined83.3 M undefined
20131.46 B undefined45.5 M undefined22.6 M undefined
20121.11 B undefined33.2 M undefined21.8 M undefined
20111.03 B undefined29.1 M undefined24.2 M undefined
20101.09 B undefined32.5 M undefined18.7 M undefined
20091.1 B undefined28.7 M undefined16.1 M undefined
2008936.4 M undefined26.5 M undefined14.3 M undefined
2007268.1 M undefined15.4 M undefined9 M undefined
2006268.8 M undefined17.9 M undefined10.3 M undefined
2005259.3 M undefined15.7 M undefined8.3 M undefined

EBOS Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B AUD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B AUD)
NET INCOME (M AUD)
NET INCOME GROWTH (%)
DIV. (AUD)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
0.060.060.060.080.170.20.20.260.270.270.941.11.091.031.111.465.215.856.436.846.996.938.779.210.7312.2413.1912.313.1813.93
-9.096.6731.25101.1917.750.5029.503.47-249.2517.09-0.18-5.858.0631.18256.9912.189.976.382.13-0.8026.484.9916.6514.007.78-6.757.145.71
2,967.272,720.002,550.001,942.86965.68820.10816.00630.12608.96608.9611.7511.1311.1510.1911.4112.269.889.899.529.7711.2511.6310.4610.6911.4912.6412.3713.2712.3911.72
00000000000.110.120.120.110.130.180.520.580.610.670.790.810.920.981.231.551.63000
2334557810914161824212283102115119137137162185202253271271311346
-50.00-33.3325.00-40.0014.2925.00-10.0055.5614.2912.5033.33-12.504.76277.2722.8912.753.4815.13-18.2514.209.1925.257.11-14.7611.25
------------------------------
------------------------------
19.519.635.73434.334.534.834.834.938.452.456.857.359.359.953.4146.7149.67151.13151.77151.85153.32161.56163.71176.95190.6192.17000
------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The EBOS Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the EBOS Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (B)
OTHER REC. (M)
INVENTORIES (B)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (B)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (B)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (B)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (B)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                     
0.11.90.10.210.51.52.51.61.712.92746.177.141.2167.882.4105.55108.9145.48149.87166.62244.78168.95517.32211.89216.88
0.010.010.010.010.030.030.030.030.030.040.120.120.120.120.140.610.640.761.180.910.890.870.981.11.281.381.37
0.20.10.50.52.10.60.61.91.42.241.10.91.61.711.111.215.4516.0124.1424.7732.1340.1257.996.76120.2126.57
0.010.010.020.020.030.030.030.030.040.040.10.10.10.090.130.470.460.50.520.510.540.720.740.781.11.231.21
000000001.612.31.82.22.13.79.67.69.757.467.0410.3510.2112.5914.1651.6957.3155.48
0.020.020.030.030.060.050.060.070.070.080.240.250.270.290.311.281.21.391.841.61.611.82.022.123.053.012.98
2.71.952.811.611.411.11099.818.315.614.513.118.481.398.2107.5594.6124.51170.5180.97402.42464.94572.94660.68834.42
006.46.603.23.500.20.20.100014.416.122.433.6434.4433.5346.2850.8157.2656.5658.8969.2589.37
00000.60.80.93.10.500000000000000096.76120.20
2.32.22.12.12.97.37.775.35.72019.619.518.424.4130.9124.5142.99132.66175.84180.59170.15166.29162.44543.2515.26529.91
0000000.010.020.020.020.110.110.110.090.140.610.670.740.750.90.890.950.9711.951.982.07
0.20.20.20.50.40.10.20.61.92.34.15.95.34.2629.13446.9642.8144.248.6855131.37141.84194.09208.6240.48
0.0100.020.010.020.030.030.040.040.040.150.150.150.120.20.870.951.071.061.281.341.41.731.833.413.553.76
0.020.030.050.050.080.080.080.110.110.120.390.40.420.420.522.152.142.462.892.882.953.23.753.956.466.566.74
                                                     
000.020.020.020.020.020.020.020.060.080.080.090.080.080.170.80.850.80.80.760.930.960.991.811.891.94
000000000000000000000000000
5.86.77.310.11315.118.822.123.128.631.545.362.568.778.590.9136.6182.72216.95249.74310.64327.57378.61443.8492.89575.64550.74
0.20.50.70.5-0.2-0.3-0.4-0.50.5-0.41.5-0.301.50.2-3.1-27.5-18.5-36.96-31.26-22.79-17.05-25.15-26.4-38.64-31.11-36.94
00000000000000000000-1.55000000
0.010.010.030.030.040.040.040.050.050.090.120.130.150.150.160.260.911.010.981.021.051.241.311.412.262.432.45
0.010.010.020.010.020.020.020.030.020.020.180.180.190.190.20.660.720.831.391.11.081.191.31.471.772.091.99
000000000003.84.53.96.621.826.832.3632.2436.7540.7240.8142.7758.7176.1780.0581.85
23.11.81.21.51.61.82.110.17.515.714.816.914.519.4835.258.7105.8389.3103.14105.37121.32147.2196.93297.81399.45227.15
0.10.40.40.13.64.83.24.92.90.60.20000.2164.3121.2147.6996.87139.01147.15168.31179.41116.64221.5242.12180.75
0.20.70.50.51.32.62.60.118.21.166.12.20.108.419.521.30.150.130.8700101.3636.5152.6350.14642.2
0.010.020.020.020.030.030.030.030.050.030.260.20.210.210.241.70.951.121.611.381.371.521.771.882.522.663.12
00000.010.010.010.020.010.0100.060.050.040.10.130.230.260.240.40.440.360.530.531.271.190.82
00000.2000006.26.17.56.78.54140.347.0841.7645.5553.2657.33128.83127.43241.41259.25298.74
00000.1000004.24.64.64.14.112.21314.3315.9517.5719.4320.5511.2911.46180.7125.782.41
00000.010.010.010.020.010.010.010.070.060.060.110.180.290.320.290.460.510.440.670.671.71.481.2
0.020.020.020.020.040.040.040.060.060.040.270.270.270.260.351.891.241.441.911.841.881.962.442.544.214.134.33
0.020.030.050.050.070.080.080.110.110.120.390.40.420.420.512.152.142.462.892.862.933.213.753.966.486.576.78
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of EBOS Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand EBOS Group's financial health and stability.

Assets

EBOS Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that EBOS Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of EBOS Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into EBOS Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M AUD)
DEPRECIATION (M AUD)
DEFERRED TAXES (M AUD)
CHANGES IN WORKING CAPITAL (M AUD)
NON-CASH ITEM (M AUD)
PAID INTEREST (M AUD)
PAID TAXES (M AUD)
NET CASH FLOW FROM OPERATING ACTIVITIES (M AUD)
CAPITAL EXPENDITURES (M AUD)
CASH FLOW FROM INVESTING ACTIVITIES (M AUD)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M AUD)
INTEREST INCOME AND EXPENSES (M AUD)
NET DEBT CHANGE (M AUD)
NET CHANGE IN EQUITY (M AUD)
CASH FLOW FROM FINANCING ACTIVITIES (B AUD)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (AUD)
TOTAL DIVIDENDS PAID (M AUD)
NET CHANGE IN CASH FLOW (M AUD)
FREE CASH FLOW (M AUD)
SHARE-BASED COMPENSATION (M AUD)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
000000000000000000000000202253
00000000000000000000000081124
000000000000000000000000-167
0000000000000111223223261320
000000000000000000000000-2015
00000-1-1-2-2-1-7-6-4-3-5-7-27-23-20-18-22-27-31-28-31-79
-1-1-2-1-2-2-3-5-5-3-7-3-6-9-6-10-26-51-49-58-60-55-69-72-115-144
1-125887676242733162121103128202129162118229298248391
-1-1-10-1-6-20-1-2-5-2-2-3-3-3-31-14-15-33-58-34-29-82-89-98
-10-71-7-11-2-14-7-4-79-1-231-8831-365-76-94-198-88-120-73-113-1,396-154
01-61-5-50-13-6-2-741034-8535-333-61-78-165-30-85-44-31-1,306-55
00000000000000000000000000
13-1-3031136-2549-9-10-2416698-3219218-517-167864-450
008000000312400107414618700168293279179
000-0.01-00-00.01000.07-0.01-0.01-0.020.030.060.17-0.03-0.10.11-0.070.02-0.07-0.261.5-0.55
--------------------------
-1-1-2-2-3-3-4-5-5-6-5-2-2-14-12-17-47-61-69-85-91-99-111-124-154-175
32278101412151451506160-415555220279241237214406316730289
0.4-2.11.34.56.62.84.95.16.24.21924.83113.618.918.171.4114.0518795.4104.0684.34199.91216.05159.1293.02
00000000000000000000000000

EBOS Group stock margins

The EBOS Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of EBOS Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for EBOS Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the EBOS Group's sales revenue. A higher gross margin percentage indicates that the EBOS Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the EBOS Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the EBOS Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the EBOS Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the EBOS Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the EBOS Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

EBOS Group Margin History

EBOS Group Gross marginEBOS Group Profit marginEBOS Group EBIT marginEBOS Group Profit margin
2027e12.38 %4.23 %2.49 %
2026e12.38 %4.12 %2.36 %
2025e12.38 %3.95 %2.21 %
202412.38 %3.66 %2.06 %
202312.65 %3.64 %2.07 %
202211.49 %3.22 %1.89 %
202110.7 %3.12 %2.01 %
202010.47 %2.96 %1.85 %
201911.63 %3.25 %1.99 %
201811.26 %3.06 %1.96 %
20179.77 %2.77 %1.75 %
20169.53 %2.79 %1.79 %
20159.89 %2.79 %1.75 %
20149.88 %2.68 %1.6 %
201312.26 %3.12 %1.55 %
201211.45 %2.98 %1.96 %
201110.19 %2.82 %2.35 %
201011.21 %2.97 %1.71 %
200911.15 %2.62 %1.47 %
200811.78 %2.83 %1.53 %
200712.38 %5.74 %3.36 %
200612.38 %6.66 %3.83 %
200512.38 %6.05 %3.2 %

EBOS Group Stock Sales Revenue, EBIT, Earnings per Share

The EBOS Group earnings per share therefore indicates how much revenue EBOS Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue EBOS Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates EBOS Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of EBOS Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating EBOS Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

EBOS Group Revenue, EBIT and net profit per share

DateEBOS Group Sales per ShareEBOS Group EBIT per shareEBOS Group Earnings per Share
2027e72.49 undefined0 undefined1.8 undefined
2026e68.57 undefined0 undefined1.62 undefined
2025e64 undefined0 undefined1.41 undefined
202468.63 undefined2.51 undefined1.41 undefined
202364.2 undefined2.33 undefined1.33 undefined
202260.66 undefined1.95 undefined1.15 undefined
202156.21 undefined1.76 undefined1.13 undefined
202054.26 undefined1.61 undefined1.01 undefined
201945.2 undefined1.47 undefined0.9 undefined
201846.01 undefined1.41 undefined0.9 undefined
201745.07 undefined1.25 undefined0.79 undefined
201642.55 undefined1.19 undefined0.76 undefined
201539.07 undefined1.09 undefined0.68 undefined
201435.53 undefined0.95 undefined0.57 undefined
201327.34 undefined0.85 undefined0.42 undefined
201218.58 undefined0.55 undefined0.36 undefined
201117.38 undefined0.49 undefined0.41 undefined
201019.1 undefined0.57 undefined0.33 undefined
200919.3 undefined0.51 undefined0.28 undefined
200817.87 undefined0.51 undefined0.27 undefined
20076.98 undefined0.4 undefined0.23 undefined
20067.7 undefined0.51 undefined0.3 undefined
20057.45 undefined0.45 undefined0.24 undefined

EBOS Group business model

The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry. EBOS Group is one of the most popular companies on Eulerpool.com.

EBOS Group SWOT Analysis

Strengths

EBOS Group Ltd, a leading healthcare and animal care provider, holds several strengths that contribute to its success:

  • Strong market presence with a wide range of portfolio offerings.
  • Well-established distribution network enabling efficient delivery of products.
  • Strong financial performance and robust profitability.
  • Strong relationships with suppliers and customers.

Weaknesses

Despite its strengths, EBOS Group Ltd also faces certain weaknesses:

  • Relatively high dependency on a limited number of key suppliers.
  • Geographic concentration, making it vulnerable to regional economic and political instability.
  • Some product lines have faced pricing pressures and increased competition.
  • Higher operating costs due to regulatory compliance requirements.

Opportunities

EBOS Group Ltd can capitalize on the following opportunities in the market:

  • Increasing global demand for healthcare and animal care products.
  • Growing awareness and focus on preventive healthcare.
  • Expansion into emerging markets with untapped potential.
  • Potential for strategic partnerships or acquisitions to enhance the product portfolio.

Threats

However, EBOS Group Ltd also faces certain threats that could impact its performance:

  • Increase in regulatory compliance requirements, leading to higher costs.
  • Intense competition and price pressures in the healthcare and animal care sectors.
  • Fluctuating currency exchange rates impacting imports and exports.
  • Technological advancements requiring continuous investments in systems and infrastructure.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

EBOS Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

EBOS Group historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

EBOS Group shares outstanding

The number of shares was EBOS Group in 2024 — This indicates how many shares 192.168 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue EBOS Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates EBOS Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of EBOS Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating EBOS Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

EBOS Group stock splits

In EBOS Group's history, there have been no stock splits.

EBOS Group dividend history and estimates

In 2024, EBOS Group paid a dividend amounting to 2.17 AUD. Dividend means that EBOS Group distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for EBOS Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify EBOS Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating EBOS Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

EBOS Group Dividend History

DateEBOS Group Dividend
2027e2.26 undefined
2026e2.26 undefined
2025e2.24 undefined
20242.17 undefined
20231.42 undefined
20221.1 undefined
20210.04 undefined
20200.43 undefined
20190.39 undefined
20180.4 undefined
20170.03 undefined
20160.37 undefined
20150.29 undefined
20140.48 undefined
20130.21 undefined
20120.45 undefined
20110.4 undefined
20100.49 undefined
20090.33 undefined
20080.33 undefined
20070.32 undefined
20060.32 undefined
20050.31 undefined

EBOS Group dividend payout ratio

In 2024, EBOS Group had a payout ratio of 48.8%. The payout ratio indicates the percentage of the company's profits that EBOS Group distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for EBOS Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for EBOS Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate EBOS Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

EBOS Group Payout Ratio History

DateEBOS Group Payout ratio
2027e55.35 %
2026e53.33 %
2025e63.92 %
202448.8 %
202347.27 %
202295.69 %
20213.45 %
202042.66 %
201943.97 %
201844.7 %
20173.53 %
201648.37 %
201541.92 %
201483.82 %
201349.75 %
2012126.36 %
2011100.97 %
2010148.76 %
2009117.88 %
2008122.48 %
2007140.65 %
2006107.83 %
2005128.79 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for EBOS Group.

EBOS Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20190.47 AUD0.46 AUD (-3.73 %)2019 Q4
6/30/20160.4 AUD0.38 AUD (-3.95 %)2016 Q4
12/31/20150.39 AUD0.39 AUD (-0.56 %)2016 Q2
12/31/20140.34 AUD0.33 AUD (-1.95 %)2015 Q2
1

Eulerpool ESG Scorecard© for the EBOS Group stock

Eulerpool World ESG Rating (EESG©)

71/ 100

🌱 Environment

78

👫 Social

60

🏛️ Governance

75

Environment

Scope 1 - Direct Emissions
3,530
Scope 2 - Indirect emissions from purchased energy
18,289
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
21,820
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees56
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

EBOS Group shareholders

%
Name
Stocks
Change
Date
19.09683 % Sybos Holdings Pte. Ltd.36,698,002556,1937/24/2024
4.10658 % Capital Research Global Investors7,891,539-487,10612/31/2024
2.89732 % Accident Compensation Corporation5,567,7221,567,9917/24/2024
2.51592 % The Vanguard Group, Inc.4,834,7956,5621/31/2025
1.30305 % ANZ New Zealand Investments Limited2,504,047298,2497/24/2024
1.19202 % Norges Bank Investment Management (NBIM)2,290,67929,74912/31/2024
1.04620 % BlackRock Institutional Trust Company, N.A.2,010,4693,0451/31/2025
0.93557 % Whyte Adder No. 3 Ltd.1,797,87407/24/2024
0.27796 % Charles Schwab Investment Management, Inc.534,1431,7401/31/2025
0.27694 % Magellan Asset Management Limited532,181-20,4189/30/2024
1
2
3
4
5
...
10

EBOS Group Executives and Management Board

Mr. John Matthew Cullity

EBOS Group Chief Executive Officer
Compensation 6.65 M AUD

Ms. Elizabeth Coutts

EBOS Group Independent Non-Executive Chairman of the Board
Compensation 408,450 AUD

Mr. Stuart McLauchlan

EBOS Group Non-Executive Independent Director
Compensation 235,725 AUD

Dr. Tracey Batten

(58)
EBOS Group Non-Executive Independent Director
Compensation 193,725 AUD

Mr. Mark Bloom

(66)
EBOS Group Non-Executive Independent Director
Compensation 190,838 AUD
1
2
3
4

Most common questions regarding EBOS Group

What values and corporate philosophy does EBOS Group represent?

EBOS Group Ltd represents values of integrity, collaboration, and excellence in its corporate philosophy. As a leading Australasian distributor of healthcare, medical, and pharmaceutical products, EBOS Group is committed to delivering high-quality solutions and services to its customers. The company's strong emphasis on ethical business practices and customer satisfaction has positioned it as a trusted partner in the healthcare industry. With a focus on continuous improvement and innovation, EBOS Group strives to enhance the well-being of individuals and communities through its diverse range of products and services.

In which countries and regions is EBOS Group primarily present?

EBOS Group Ltd is primarily present in Australia and New Zealand.

What significant milestones has the company EBOS Group achieved?

EBOS Group Ltd, a leading provider of healthcare and animal care products, has achieved several significant milestones. Firstly, the company expanded its operations internationally, establishing a strong presence in Australia and New Zealand. Secondly, EBOS made strategic acquisitions, including those of Symbion and Terry White Group, which further strengthened its market position. Additionally, EBOS achieved consistent revenue growth year on year, demonstrating its ability to deliver value to shareholders. Moreover, the company was recognized for its excellence through numerous awards, such as the Deloitte Top 200 Company of the Year. Overall, EBOS Group Ltd has successfully grown its business, expanded its reach, and gained industry recognition, solidifying its position in the market.

What is the history and background of the company EBOS Group?

EBOS Group Ltd is a leading healthcare and animal care company based in New Zealand and Australia. With a rich history dating back to 1922, EBOS has grown to become a highly reputable player in the industry. Originally established as a pharmaceutical wholesaler, the company expanded its focus to healthcare and animal care through strategic acquisitions and partnerships. Today, EBOS Group Ltd operates across numerous sectors, including medical, dental, hospital, and retail pharmacy, as well as animal care and pet supplies. The company's commitment to delivering innovative solutions, along with its extensive network of partners and customer-centric approach, has contributed to its continued success and growth.

Who are the main competitors of EBOS Group in the market?

The main competitors of EBOS Group Ltd in the market include companies such as Sigma Healthcare Ltd, Australian Pharmaceutical Industries Limited (API), and New Zealand Pharmaceuticals Limited.

In which industries is EBOS Group primarily active?

EBOS Group Ltd is primarily active in the healthcare and pharmaceutical industries.

What is the business model of EBOS Group?

The business model of EBOS Group Ltd revolves around its position as a leading distributor of healthcare, laboratory, and pharmaceutical products. EBOS Group Ltd operates through two segments: Healthcare and Animal Care. The Healthcare segment supplies a broad range of medical products to public and private hospitals, pharmacies, and healthcare providers. The Animal Care segment focuses on providing veterinary products and services to veterinarians, farmers, and other animal healthcare professionals. With its robust distribution network and comprehensive product portfolio, EBOS Group Ltd strives to enhance healthcare outcomes and deliver value to its customers in the healthcare and animal care sectors.

What is the P/E ratio of EBOS Group 2025?

The EBOS Group P/E ratio is 24.27.

What is the P/S ratio of EBOS Group 2025?

The EBOS Group P/S ratio is 0.54.

What is the Quality Investing of EBOS Group?

The Quality Investing for EBOS Group is 7/10.

What is the revenue of EBOS Group 2025?

The expected EBOS Group revenue is 12.3 B AUD.

How high is the profit of EBOS Group 2025?

The expected EBOS Group profit is 271.47 M AUD.

What is the business model of EBOS Group

The EBOS Group Limited is a leading distributor of medical and pharmaceutical products in Australia, New Zealand, and Asia. Their business model is based on supplying products to medical facilities, pharmacies, and healthcare providers. The company operates in various sectors, including Healthcare, Animal Care, and Scientific. In the Healthcare sector, the EBOS Group is an important supplier of medical devices and consumables. They offer a wide range of products, ranging from surgical instruments and diagnostic devices to incontinence products and bandages. In the Animal Care sector, EBOS holds an extensive product list of veterinary medicines and supplies. The EBOS Group is one of the largest suppliers of animal medicines in Australia and New Zealand. The company works closely with veterinarians and professionals in animal health to ensure the best possible fulfillment of the needs of pets and livestock. In the Scientific sector, EBOS trades in laboratory equipment, chemicals, and other scientific products. The company also provides services such as calibration, repair, and maintenance of laboratory equipment. The EBOS Group aims to provide its customers with the highest quality and most innovative products and services. The company holds a wide range of products and brands in stock, including its own brands and established brands such as Johnson & Johnson and Roche. The business model of the EBOS Group is based on providing products and services that meet the needs of its customers. The company has established a network of distribution centers throughout Australia, New Zealand, and Asia to ensure that its customers are supplied quickly and effectively. The EBOS Group also has a strong online presence to enable its customers to easily purchase and access their products. The company also utilizes advanced IT systems and technologies to optimize the ordering and delivery process and ensure fast and reliable product delivery. Overall, the business model of the EBOS Group offers a wide range of high-quality products and services for diverse customer needs. The company is well positioned to leverage growth in the Healthcare, Animal Care, and Scientific sectors in Australia, New Zealand, and Asia, and strengthen its position as a leading company in the medical and pharmaceutical industry. Answer: The EBOS Group Limited is a leading distributor of medical and pharmaceutical products in Australia, New Zealand, and Asia. They provide products to medical facilities, pharmacies, and healthcare providers, and operate in the Healthcare, Animal Care, and Scientific sectors. They offer a wide range of products and brands, have a strong online presence, and utilize advanced technology to optimize the ordering and delivery process. The EBOS Group aims to provide high-quality products and services and is well positioned for growth in the industry.

What is the EBOS Group dividend?

EBOS Group pays a dividend of 1.1 AUD distributed over payouts per year.

How often does EBOS Group pay dividends?

The dividend cannot currently be calculated for EBOS Group or the company does not pay out a dividend.

What is the EBOS Group ISIN?

The ISIN of EBOS Group is NZEBOE0001S6.

What is the EBOS Group WKN?

The WKN of EBOS Group is 724635.

What is the EBOS Group ticker?

The ticker of EBOS Group is EBO.NZ.

How much dividend does EBOS Group pay?

Over the past 12 months, EBOS Group paid a dividend of 2.17 AUD . This corresponds to a dividend yield of about 6.34 %. For the coming 12 months, EBOS Group is expected to pay a dividend of 2.26 AUD.

What is the dividend yield of EBOS Group?

The current dividend yield of EBOS Group is 6.34 %.

When does EBOS Group pay dividends?

EBOS Group pays a quarterly dividend. This is distributed in the months of September, September, March, March.

How secure is the dividend of EBOS Group?

EBOS Group paid dividends every year for the past 23 years.

What is the dividend of EBOS Group?

For the upcoming 12 months, dividends amounting to 2.26 AUD are expected. This corresponds to a dividend yield of 6.6 %.

In which sector is EBOS Group located?

EBOS Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von EBOS Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of EBOS Group from 3/21/2025 amounting to 0.71 AUD, you needed to have the stock in your portfolio before the ex-date on 2/28/2025.

When did EBOS Group pay the last dividend?

The last dividend was paid out on 3/21/2025.

What was the dividend of EBOS Group in the year 2024?

In the year 2024, EBOS Group distributed 1.422 AUD as dividends.

In which currency does EBOS Group pay out the dividend?

The dividends of EBOS Group are distributed in AUD.

All fundamentals about EBOS Group

Our stock analysis for EBOS Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EBOS Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.